Study Finds Reduced Radiation for HPV Oropharyngeal Cancer Patients To Be Effective 

Dr. Daniel Ma, radiation oncologist and research chair at the Mayo Clinic in Rochester, MN, conducted Phase II and Phase III clinical trials to determine if reduced doses of radiation successfully eliminate cancer while preserving the patients’ quality of life. The Phase III randomized clinical trial found that reducing radiation doses by as much as half can not only be successful in destroying cancerous tumors; it reduces debilitating side effects.
© 2022 HPVANDME, INC. If you like our videos, please subscribe to our RU-vid channel.
We need 1000 subscribers for HPVANDME, a nonprofit 501(c)(3) organization, to get paid for the RU-vid ads that you see on our videos. Until then, only RU-vid gets paid for these ads.
Thank you for your support.
All rights reserved. This video may not be embedded without permission. Any reproduction or illegal distribution of the content in any form will result in immediate action against the person concerned.
SIGN UP FOR OUR MONTHLY NEWSLETTER at www.hpvandme.org